UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 990

Sortiert nach

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

Molecular cancer, 2018-08, Vol.17 (1), p.129-129, Article 129

2018

Volltextzugriff (PDF)

High-Resolution Expression Map of the Arabidopsis Root Reveals Alternative Splicing and lincRNA Regulation

Developmental cell, 2016-11, Vol.39 (4), p.508-522

2016

Volltextzugriff (PDF)

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer

Nature communications, 2022-02, Vol.13 (1), p.816-816, Article 816

2022

Volltextzugriff (PDF)

Chimeric antigen receptor T cells: a novel therapy for solid tumors

Journal of hematology and oncology, 2017-03, Vol.10 (1), p.78-78, Article 78

2017

Volltextzugriff (PDF)

Down-Regulation of Lncrna MALAT1 Attenuates Neuronal Cell Death Through Suppressing Beclin1-Dependent Autophagy by Regulating Mir-30a in Cerebral Ischemic Stroke

Cellular physiology and biochemistry, 2017-01, Vol.43 (1), p.182-194

2017

Volltextzugriff (PDF)

Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options

Frontiers in immunology, 2022-01, Vol.13, p.828330-828330

2022

Volltextzugriff (PDF)

Ferroptosis: a double-edged sword mediating immune tolerance of cancer

Cell death & disease, 2022-11, Vol.13 (11), p.925-925, Article 925

2022

Volltextzugriff (PDF)

Immunosenescence: molecular mechanisms and diseases

Signal transduction and targeted therapy, 2023-05, Vol.8 (1), p.200-200, Article 200

2023

Volltextzugriff (PDF)

A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma

Journal of translational medicine, 2021-01, Vol.19 (1), p.5-5, Article 5

2021

Volltextzugriff (PDF)

Biological and pharmacological roles of m6A modifications in cancer drug resistance

Molecular cancer, 2022-12, Vol.21 (1), p.1-220, Article 220

2022

Volltextzugriff (PDF)

A retrospective pilot study of transarterial chemoembolisation using camrelizumab-eluting Callisphere beads for unresectable hepatocellular carcinoma

BMC cancer, 2023-11, Vol.23 (1), p.1-1144, Article 1144

2023

Volltextzugriff (PDF)

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma

Frontiers in oncology, 2021-03, Vol.11, p.619242-619242

2021

Volltextzugriff (PDF)

A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy

Frontiers in immunology, 2022-01, Vol.13, p.809761-809761

2022

Volltextzugriff (PDF)

TACE sequential MWA guided by cone-beam computed tomography in the treatment of small hepatocellular carcinoma under the hepatic dome

BMC cancer, 2023-06, Vol.23 (1), p.600-600, Article 600

2023

Volltextzugriff (PDF)

Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells

Biomedicine & pharmacotherapy, 2016-12, Vol.84, p.1748-1759

2016

Volltextzugriff (PDF)

Recent advances of bispecific antibodies in solid tumors

Journal of hematology and oncology, 2017-09, Vol.10 (1), p.155-155, Article 155

2017

Volltextzugriff (PDF)

Construction of antibacterial photothermal PCL/AgNPs/BP nanofibers for infected wound healing

Materials & design, 2023-02, Vol.226, p.111670, Article 111670

2023

Volltextzugriff (PDF)

Transarterial chemoembolization of unresectable renal cell carcinoma with doxorubicin-loaded CalliSpheres drug-eluting beads

Scientific reports, 2022-05, Vol.12 (1), p.8136-8136, Article 8136

2022

Volltextzugriff (PDF)

The safety and efficacy of oxaliplatin-loaded drug-eluting beads transarterial chemoembolization for the treatment of unresectable or advanced lung cancer

Frontiers in pharmacology, 2022-11, Vol.13, p.1079707

2022

Volltextzugriff (PDF)

Retraction notice to “MiR-29b aggravates lipopolysaccharide-induced endothelial cells inflammatory damage by regulation of NF-κB and JNK signaling pathways” [Biomed. Pharmacother. 99 (2018) 451–461]

Biomedicine & pharmacotherapy, 2022-07, Vol.151, p.112859-112859, Article 112859

2022

Volltextzugriff (PDF)

Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients

Frontiers in pharmacology, 2021-10, Vol.12, p.709060-709060

2021

Volltextzugriff (PDF)

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

Journal for immunotherapy of cancer, 2022-01, Vol.10 (1), p.e003777

2022

Volltextzugriff (PDF)

LINC00702/miR-4652-3p/ZEB1 axis promotes the progression of malignant meningioma through activating Wnt/β-catenin pathway

Biomedicine & pharmacotherapy, 2019-05, Vol.113, p.108718-108718, Article 108718

2019

Volltextzugriff (PDF)

DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis

Journal of hematology and oncology, 2018-04, Vol.11 (1), p.53-16, Article 53

2018

Volltextzugriff (PDF)

Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer

EBioMedicine, 2022-01, Vol.75, p.103750-103750, Article 103750

2022

Volltextzugriff (PDF)

1 – 25 von 990

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(850)
Mit Volltextzugriff
(937)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(750)
Life Sciences & Biomedicine
(464)
Humans
(235)
Technology
(227)
Engineering
(135)
Physical Sciences
(125)
Oncology
(109)
Female
(103)
Male
(101)
Patients
(87)
Tumors
(77)
Engineering, Electrical & Electronic
(74)
Materials Science
(74)
Retrospective Studies
(74)
Middle Aged
(73)
Treatment Outcome
(70)
Science & Technology - Other Topics
(69)
Chemistry
(68)
Surgery
(68)
Animals
(67)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors

High-Resolution Expression Map of the Arabidopsis Root Reveals Alternative Splicing and lincRNA Regulation

Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer

Chimeric antigen receptor T cells: a novel therapy for solid tumors

Down-Regulation of Lncrna MALAT1 Attenuates Neuronal Cell Death Through Suppressing Beclin1-Dependent Autophagy by Regulating Mir-30a in Cerebral Ischemic Stroke

Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options

Ferroptosis: a double-edged sword mediating immune tolerance of cancer

Immunosenescence: molecular mechanisms and diseases

A novel immune classification reveals distinct immune escape mechanism and genomic alterations: implications for immunotherapy in hepatocellular carcinoma

Biological and pharmacological roles of m6A modifications in cancer drug resistance

A retrospective pilot study of transarterial chemoembolisation using camrelizumab-eluting Callisphere beads for unresectable hepatocellular carcinoma

The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma

A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy

TACE sequential MWA guided by cone-beam computed tomography in the treatment of small hepatocellular carcinoma under the hepatic dome

Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells

Recent advances of bispecific antibodies in solid tumors

Construction of antibacterial photothermal PCL/AgNPs/BP nanofibers for infected wound healing

Transarterial chemoembolization of unresectable renal cell carcinoma with doxorubicin-loaded CalliSpheres drug-eluting beads

The safety and efficacy of oxaliplatin-loaded drug-eluting beads transarterial chemoembolization for the treatment of unresectable or advanced lung cancer

Retraction notice to “MiR-29b aggravates lipopolysaccharide-induced endothelial cells inflammatory damage by regulation of NF-κB and JNK signaling pathways” [Biomed. Pharmacother. 99 (2018) 451–461]

Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients

Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

LINC00702/miR-4652-3p/ZEB1 axis promotes the progression of malignant meningioma through activating Wnt/β-catenin pathway

DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis

Integrative analysis from multi-center studies identities a consensus machine learning-derived lncRNA signature for stage II/III colorectal cancer

Aktive Filter

Suchergebnisse filtern